chrisvoncsefalvay/vaers-outcomes huggingface dataset:
First night after vaccine: could not sleep due to significant pain in my arm and constantly feeling too hot and then too cold, in addition to night sweats.  Day 1: could not walk (had to crawl to move around), extreme fatigue, dizziness, hallucinations, exceptionally poor motor skills, no real memory of anything I did that day, brain "mush" to where I could not understand words spoken to me, extreme arm pain persisted Day 2: slept 14 hours and took a 4 hour nap that day, able to walk but could not use stairs, fatigue, dizziness, poor motor skills, no memory of what I did this day, brain "mush" persists, extreme arm pain persists Day 3: slept 12 hours and took a 5 hour nap, able to walk but not use stairs, fatigue, dizziness, poor motor skills, memory improves but still poor, brain "mush" persists, extreme arm pain persists Day 4: slept in again long at night and had a long nap, able to use stairs again but very slowly, fatigue, dizziness, poor motor skills, memory improves but the ability to recall past experiences and recall words remain poor, arm pain persists Day 5: slept in again long at night and had a long nap, able to use stairs again but very slowly, fatigue, dizziness, poor motor skills, memory improves but the ability to recall past experiences and recall words remain poor, arm pain persists Day 6: slept in again lost at night but no longer napping, ability to use stairs finally improves, fatigue, dizziness, poor motor skills, memory improves but the ability to recall past experiences and recall words remain poor, arm pain persists  I could not drive a car until 8 days after the vaccine due to poor motor skills.  To this day (one month later) by ability to recall memories and recall words remains poor. I have troubles forming sentences because words don't come to me. To this day I cannot recall anything that happened days 1-3 after the vaccine. I was able to write this report because my partner made me take notes on how I felt. Prior to the vaccine I never had an issue with memory recall. My physical reactions cleared during the second week after the vaccine. However, the mental reactions still stubbornly persist.
Information has been received from a Nurse Practitioner concerning a 22 year old female virgin patient with no pertinent medical history no drug reactions or allergy who on 07-JUN-2007 was vaccinated with first dose of GARDASIL vaccine (lot # not reported) 0.5ml, intramuscularly. On 09-AUG-2007 patient received second dose of GARDASIL vaccine (lot # not reported) 0.5ml, intramuscularly and on 30-NOV-2007 she received third dose of GARDASIL vaccine (lot # 659439/1267U) 0.5ml, intramuscularly. Concomitant therapy included hormonal contraceptives (unspecified). Patient was virgin prior GARDASIL vaccination. In December 2008 the patient had an abnormal pap and DNA test was positive for high risk HPV. Patient sought medical attention was seen in the office. This is one of two reports from the same source. Additional information has been requested.
pt recv vax & exp severe autoimmune to rxn; described sclerosis sx which optic neuritis; pt stated partially blind;recv 3rd dose and went completely blind;
Patient reported redness, swelling and itching below the infection site. Estimated at 6 inches long and 3 inches wide. A little worse than it was 11/4.
Aches mostly in her upper legs but also a little in her arms; Extreme feeling reaction like her muscles or bones were petrifying; Night sweats; Achiness; Headache; Slight fever, fever of 102 degree F; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Aches mostly in her upper legs but also a little in her arms), IMMUNISATION REACTION (Extreme feeling reaction like her muscles or bones were petrifying), NIGHT SWEATS (Night sweats), PAIN (Achiness) and HEADACHE (Headache) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002M21A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: FLU VACCINE VII (before 1st booster in the fall). Past adverse reactions to the above products included No adverse event with FLU VACCINE VII. Concurrent medical conditions included Drug allergy (codeine and derivates), Hypercholesterolaemia (Started 35 or 40 years ago, no change in status such as improvement or worsening), Esophageal reflux (Started 25 or 30 years ago, no change in status such as improvement or worsening) and Asthma (Started 25 or 30 years ago, no change in status such as improvement or worsening). Concomitant products included FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) for Asthma, ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]) for Esophageal reflux, SIMVASTATIN for High cholesterol, FLUOXETINE HYDROCHLORIDE (PROZAC), PRIMIDONE, CALCIUM and VITAMINS NOS for an unknown indication.    On 09-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2022, the patient experienced PAIN IN EXTREMITY (Aches mostly in her upper legs but also a little in her arms), IMMUNISATION REACTION (Extreme feeling reaction like her muscles or bones were petrifying), NIGHT SWEATS (Night sweats), PAIN (Achiness), HEADACHE (Headache) and PYREXIA (Slight fever, fever of 102 degree F). On 10-Apr-2022, NIGHT SWEATS (Night sweats), PAIN (Achiness), HEADACHE (Headache) and PYREXIA (Slight fever, fever of 102 degree F) had resolved. At the time of the report, PAIN IN EXTREMITY (Aches mostly in her upper legs but also a little in her arms) and IMMUNISATION REACTION (Extreme feeling reaction like her muscles or bones were petrifying) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Apr-2022, Body temperature: 102 102°F.   No treatment was given   This case was linked to MOD-2022-607733 (Patient Link).
Swelling, itching, pain and redness at the injection site within an hour of injection. Developed a nodule in left deltoid lasting more than 10 days. Swelling is decreasing but still present at the time of this report.
This case was reported by a consumer via GSK employee and described the occurrence of influenza in an adult female subject who was vaccinated with Influenza vaccine unspecified (manufacturer unspecified). A physician or other health care professional has not verified this report. On an unspecified date in October 2013 the subject received a dose of Influenza vaccine unspecified (unknown). On 29 December 2013, 2 months after vaccination with Influenza vaccine unspecified, the subject experienced influenza and vaccination failure. "I don't I have ever been this sick!". The subject went to the doctors on 02 January 2014 to get pain medications "cause I can't sleep with all the hurting and high fevers". The subject reported "probably choking and having chills on New Year's Eve (31 December 2013)". The subject reported her "throat is do does" (not specified). On 03 January 2014 the subject felt "a little better since the doctor gave me something to make me rest. I slept finally last night some. Still can't get out of chair or bed and thy oat dire and coughing bad". The doctor told the subject to eat. The subject stated she had "no fever for two days so that is good". At the time of reporting the high fevers resolved; influenza, sick, can't sleep well all night and pain were improved. The events of decreased ability to perform daily activities, cough and lack of appetite were unresolved; choking, chills and throat disorder were unspecified. This case was assessed as medically serious by GSK.
Dizziness, Shaking, Shortness of Breath, Cold extremities, General weakness.  Assessed by Fire Department and transported to local hospital for further evaluation.
Very rapid heartbeat starting about 12 hours after first Moderna dose.  Lasting on and off for almost 2 weeks.
Pt recvd 3 doses of Engerix-B & was found to be a non-responder;
mild COVID symptoms; front line nurse and received it because of that; This is a spontaneous report from a contactable nurse. A female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date at single dose for treating COVID patients. Medical history included COVID. Concomitant medications were unknown. The patient had COVID previously, received the vaccine, and was currently experiencing mild COVID symptoms. The patient received vaccine from the hospital, so there was no prescriber. Patient was a front line nurse and received it because of that. Outcome of the events was unknown.   Information about batch/lot number has been requested.
Pt administered H1N1 Flu vaccine intranasal instead of intramuscular. No symptoms of flu notes as of 12/16/09. Thinking that this is protocol no MD order in place.
Warm to the touch; Large red rash, almost 6 inches long, 3 inches wide; Little swollen; Large red rash, almost 6 inches long, 3 inches wide; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to the touch), VACCINATION SITE SWELLING (Little swollen) and VACCINATION SITE RASH (Large red rash, almost 6 inches long, 3 inches wide) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 626L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Warm to the touch), VACCINATION SITE SWELLING (Little swollen) and VACCINATION SITE RASH (Large red rash, almost 6 inches long, 3 inches wide). At the time of the report, VACCINATION SITE WARMTH (Warm to the touch), VACCINATION SITE SWELLING (Little swollen) and VACCINATION SITE RASH (Large red rash, almost 6 inches long, 3 inches wide) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  Treatment Cold compress, hydrocortisone, Benadryl
His psoriasis was cured after he got his vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 04Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "psoriasis" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose: 1), for Covid-19 Immunization. The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), outcome "unknown", described as "His psoriasis was cured after he got his vaccine".  Additional information: His psoriasis was cured after he got his vaccine. Patient stated, "The reason was that he called Pfizer was that he wanted to report that since he had his full vaccination which was, he got his second shot on 04Mar. He suffered from psoriasis, fairly bad and it had cleared up on his body. So, he wanted to let Pfizer know the side effect for me of having your vaccine was that it cleared my psoriasis." When paraphrased the concern, Patient stated, "Not completely but 90% cleared. He just wanted to report something positive."  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
blood pressure all over the place; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of blood pressure fluctuation in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced blood pressure fluctuation (Verbatim: blood pressure all over the place).  The outcome of the blood pressure fluctuation was not reported.   It was unknown if the reporter considered the blood pressure fluctuation to be related to Shingles vaccine.     It was unknown if the company considered the blood pressure fluctuation to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 05-MAR-2023 This case was reported by the patient's wife via interactive digital media. The patient got the vaccine a few weeks ago and it had his blood pressure all over the place. The follow-up could not be possible as no contact details were available.
Cellulitis and lymphoginitis, redness, swelling, streaking to lymph node, enlarged lymph node, pain with movement.
patient is very confused; instead of a full additional dose he only received a half dose(booster dose); This spontaneous case was reported by a pharmacist and describes the occurrence of CONFUSIONAL STATE (patient is very confused) and ACCIDENTAL UNDERDOSE (instead of a full additional dose he only received a half dose(booster dose)) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis and Immunocompromised. Concomitant products included ETANERCEPT (ENBREL) for Rheumatoid arthritis.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Oct-2021, the patient experienced ACCIDENTAL UNDERDOSE (instead of a full additional dose he only received a half dose(booster dose)). On an unknown date, the patient experienced CONFUSIONAL STATE (patient is very confused). At the time of the report, CONFUSIONAL STATE (patient is very confused) and ACCIDENTAL UNDERDOSE (instead of a full additional dose he only received a half dose(booster dose)) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided.
Case number PHHY2013US117629 is an initial spontaneous report from a health care professional via Vaccine Adverse Event Reporting System (VAERS reference number: 496989) website on 15 Oct 2013. This case refers to 32-year-old male patient. His medical history and concomitant medications were not reported. He was vaccinated with influenza vaccine (unknown manufacturer, batch number: not reported, so conservatively coded as Seasonal Influenza vaccine INN) intramuscularly on an unknown date. It was reported that the patient had allergy to influenza vaccine. The outcome, seriousness and causality assessment of the event was not reported.
a patient received unspecified HPV vaccine on 12/27/2013 and 5/3/2016/ the patient inadvertently received 2 doses of GARDASIL 9 on 7/10/2019 and 9/25/2019; no adverse effect; a patient received unspecified HPV vaccine on 12/27/2013 and 5/3/2016/ the patient inadvertently received 2 doses of GARDASIL 9 on 7/10/2019 and 9/25/2019; a patient received unspecified HPV vaccine on 12/27/2013 and 5/3/2016/ the patient inadvertently received 2 doses of GARDASIL 9 on 7/10/2019 and 9/25/2019; a patient received unspecified HPV vaccine on 12/27/2013 and 5/3/2016; a patient received unspecified HPV vaccine on 12/27/2013 and 5/3/2016; Information has been received from a nurse practitioner, referring to a patient of unknown age and gender. The patients concurrent condition, historical condition and concomitant medication were not provided.  On 27-DEC-2013 and 03-MAY-2016, the patient received with unspecified HPV vaccine (route, dose, frequency, lot number and expiration date unknown) for prophylaxis (product origin unknown, Inappropriate schedule of product administration). On 10-JUL-2019 and 25-SEP-2019, the patient was inadvertently received 2 doses of HPV rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (lot number reported as R027577 and expiration date reported as 23-JUN-2021 for both two doses; route unknown) for prophylaxis (Interchange of vaccine products, Inappropriate schedule of product administration, Incorrect dose administered). There was no adverse effect as reported for the patient.
Visual disturbances in my right eye for over 4 hours now! It?s like a little black circle that moves when I move my eyes! Very nauseous too!
Site: Pain at Injection Site-Medium, Additional Details: The area around the injection site was numb for about 1 week.
RN administered hepatitis A intra-nasal when should have been given intra-muscular. The patient was to receive a FluMist vaccine that is given intra-nasal.
Right upper arm became red/swollen about 6x6 wide. I had fevers & chills. Right arm was hot to the touch. I went to the ER on 12/12/16 at the same facility where I received the shot. Diagnosis was cellulitis in the right shoulder where I received pneumonia shot. I was given antibiotics. From 12/8/16 to 9/2017 - I developed multiple recurring cellulitis infections in my right arm. I kept going back to the same facility where I was told it was scar tissue. In Sept 2017, I went to a different Dr who put me back on 2 types of antibiotics for a month and I was referred to an infectious disease Dr. The infectious disease Dr ordered an MRI which indicated a foreign object in my arm. I was referred to a surgeon and had surgery in December 2017 to remove the foreign object which turned out to be a cyst that had developed from the pneumonia shot.
pt recvd vax & exp lt upper quad pain in a band pattern;there was no rash;no further details were provided;
Information has been received from a registered nurse regarding a patient of an unknown age and gender. On 14-DEC-2012 at 07:45, ZOSTAVAX lot # H016765 was exposed to -14C for an estimated total time out of range of 13.25 hours.ON 18-DEC-2012 at 18:30, ZOSTAVAX lot # H016765 was exposed to -14C for an estimated total time out of range of 12.75 hours. On 22-DEC-2012 at 18:30, ZOSTAVAX lot # H016765 was exposed to -14C for an estimated total time out of range of 5 hours. On 12-JAN-2013, the patient was vaccinated with an out of range dose of ZOSTAVAX (dose and route administration were not provided) (Lot number H016765). No adverse experience had been reported. This is one of 182 reports from the same source. Additional information has been requested.
The patient developed a morbilloform rash on his face, trunk and extremities. The diagnosis is MMR reaction vs viral exanthem.
Had some discomfort at site that gradually became ?Covid arm?- swollen and red, warm and tender welt up to about 4 inches in every direction  from injection site. Have felt a solid ball under the skin where vaccine was injected and it is slowly shrinking. Some numbness in that spot from the pressure and tightness.
Syncope, vaso-vagal. Patient was standing to get vaccines, suddenly lost tone and started falling, held and placed in floor. Did not loose consciousness, had pallor, and felt weak for almost 30 minutes. At about 15 minutes patient was help and sat, received water and had sweets. After total 30 minutes, felling better, walked off the office by her own means.
woke up Saturday morning around 8am. got out of bed and passed out and collapsed. wife heard me fall and came over screaming at me to stop vomiting on the ground. she quickly realized I was not vomiting my body was just convulsing. I woke up usurer what was going on and unable to move. after about 30 min I was finally able to move some and my wife was able to help me back into the bed. I had a fever and kept going through a cycle of heavy sweets and shaking. around noon I finally had enough strength to get out of bed and slowly make my way to the living room to rest on the couch and attempt to eat.
This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (pain in arm, unbearable, excruciating pain) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 017B21A and 02A21A) for COVID-19 immunization. No medical history reported. On Apr 22, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient received first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 24, 2021, patient experienced pain in extremity (pain in arm, unbearable, excruciating pain). At the time of the report, pain in extremity (pain in arm, unbearable, excruciating pain) outcome: unknown/not provided. Treatment: Tylenol and heating pad.
This is a spontaneous report from a contactable physician reporting on his wife. An adult female patient of an unspecified age and ethnicity received PREVNAR 13 on an unspecified date. Relevant medical history and concomitant medications were not provided. The patient previously received two pneumococcal vaccines (unspecified trade names). The reported believes that the patient received the first pneumococcal vaccine when the patient was 59-years old and the second pneumococcal vaccine approximately two years ago on an unspecified date in 2010 and the patient did not have any problems after receiving the vaccines. After the patient received the PREVNAR 13, she experienced night sweats, chills, fever, intense lethargy and a lump in the left deltoid. Therapeutic measures taken in response to the night sweats, chills, fever, lethargy and lump were unknown. The clinical outcome of the events night sweats, chills, fever, lethargy and lump in deltoid were unknown.
The patient was given a KINRIX (DTaP+IPV), but should have been administered a TDAP.